StockData
Protagenic Therapeutics, Inc.new logo

Protagenic Therapeutics, Inc.new (PTIX) stock

PTIXOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026
$0.75+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.36MP/E –Yield –

Protagenic Therapeutics, Inc.new enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Protagenic Therapeutics, Inc.new's enterprise value was $791.67K on Oct 19, 2026, against $1.25M a year earlier. Over the last 5 years it ranged from -$2.68M to $21.02M, with a median of $1.54M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$791.67K+33.5%
2025Dec 31, 2025$592.87K-74.0%
2024Dec 31, 2024$2.28M–
2023Dec 29, 2023-$984.94K–
2022Dec 30, 2022-$1.24M-109.8%
2021Dec 31, 2021$12.63M–

More Protagenic Therapeutics, Inc.new figures

See a number that looks wrong?